FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Sociétés
September 12, 2017 / 7:03 AM / a year ago

BOURSE-TRANSGENE S'ENVOLE DE 8,8% APRÈS LE FEU VERT DE LA FDA POUR UNE ÉTUDE CLINIQUE

1 MINUTES DE LECTURE

BOURSE-TRANSGENE S’ENVOLE DE 8,8% APRÈS LE FEU VERT DE LA FDA POUR UNE ÉTUDE CLINIQUE

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

    Tutte le quotazioni sono differite di almeno 15 minuti. Guarda qui per la lista completa di tassi di cambio e ritardi.

    © 2018 Reuters. All Rights Reserved.